Neue Suche | Kongressdetail
Druckansicht
 
 

2nd Gene Therapy for Blood Disorders

Evvnt Promotion / evvnt
-
09.03.2021 - 11.03.2021  Virtual
Time: 08:00 to 18:00
 
Kongressthemen
There's currently a lot of exciting news circulating about the progress of genetic therapies targeting blood disorders.

As more and more promising results emerge from various clinical 3 trials, it's essential that this industry comes together to share knowledge, optimize trial design and discuss strategies for commercial launch.
Kongressorganizer (PCO)
Hanson Wade
Anmerkungen
Brochure: https://go.evvnt.com/698778-3?pid=4832

Speakers: Gabriela Denning, Vice President, Research and Development, Expression Therapeutics, Clark Paramore, Head of Value Demonstration, Vice President HEOR, bluebird bio, and more.
 

Anfragen und Anmeldung:

https://go.evvnt.com/698778-2?pid=4832
Frau Ellie Saunders
 
Kategorien
Allgemeinmedizin
Sprache
Englisch
Kongressgebühr
Conference Only Industry - Early Rate: USD 1499.00, Conference Only Industry - Standard Rate: USD 1999.00, Conference Only Academic - Early Rate: USD 1199.00, Conference Only Academic - Standard Rate: USD 1799.00
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
 
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."

AMREF - African Medical and Research FoundationHilfswerk AustriaCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioEuropean Public Health Association (EUPHA)Anästhesie in Entwicklungsländern e. V.newTreeÖsterreichisches Rotes KreuzEuropean Health Forum Gastein